{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:04:48Z","timestamp":1791493488561,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.autrev.2007.01.013","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:20:40Z","timestamp":1172060440000},"page":"432-437","source":"Crossref","is-referenced-by-count":129,"title":["Novel aspects of autoantibodies to the PM\/Scl complex: Clinical, genetic and diagnostic insights"],"prefix":"10.1016","volume":"6","author":[{"given":"Michael","family":"Mahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinout","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2007.01.013_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","article-title":"Autoantibodies in the diagnosis of systemic rheumatic diseases","volume":"24","author":"von Muhlen","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.013_bib2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2007.01.013_bib3","first-page":"80","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2007.01.013_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1172\/JCI108616","article-title":"Antinuclear antibody with distinct specificity for polymyositis","volume":"59","author":"Wolfe","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2007.01.013_bib5","first-page":"658","article-title":"Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen","volume":"11","author":"Treadwell","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.013_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00915286","article-title":"Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes","volume":"4","author":"Reichlin","year":"1984","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2007.01.013_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0074-7696(06)51005-8","article-title":"Cell and molecular biology of the exosome: how to make or break an RNA","volume":"251","author":"Schilders","year":"2006","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.autrev.2007.01.013_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.173.4.941","article-title":"Molecular characterization of an autoantigen of PM-Scl in the polymyositis\/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex","volume":"173","author":"Alderuccio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2007.01.013_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.176.4.973","article-title":"Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein","volume":"176","author":"Bluthner","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2007.01.013_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI115895","article-title":"Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen","volume":"90","author":"Ge","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2007.01.013_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1521-6616(03)00037-8","article-title":"Advances in B-cell epitope analysis of autoantigens in connective tissue diseases","volume":"107","author":"Mahler","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2007.01.013_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/ar389","article-title":"Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome","volume":"4","author":"Brouwer","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2007.01.013_bib13","doi-asserted-by":"crossref","first-page":"30698","DOI":"10.1074\/jbc.M302488200","article-title":"The association of the human PM\/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus","volume":"278","author":"Raijmakers","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2007.01.013_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.1780280221","article-title":"Nucleolar localization of the PM-Scl antigen","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.013_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2249.1990.tb05291.x","article-title":"Identification of protein components reactive with anti-PM\/Scl autoantibodies","volume":"81","author":"Gelpi","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2007.01.013_bib16","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.137.12.3802","article-title":"Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis\/scleroderma overlap syndromes","volume":"137","author":"Reimer","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2007.01.013_bib17","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.013_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.01.013_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/art.20056","article-title":"PM-Scl-75 is the main autoantigen in patients with the polymyositis\/scleroderma overlap syndrome","volume":"50","author":"Raijmakers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.013_bib20","doi-asserted-by":"crossref","first-page":"R704","DOI":"10.1186\/ar1729","article-title":"Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen","volume":"7","author":"Mahler","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2007.01.013_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O'callaghan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.013_bib22","first-page":"129","article-title":"Anti-pm\/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients","volume":"24","author":"Vandergheynst","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.013_bib23","first-page":"2169","article-title":"Patients with antibodies to both PmScl and dsDNA","volume":"31","author":"Warner","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.013_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/03009740500339961","article-title":"Dysphagia associated with anti-PM-Scl antibodies in systemic lupus erythematosus","volume":"35","author":"Borrows","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.013_bib25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/39.8.927","article-title":"Acquired haemophilia and PM-Scl antibodies","volume":"39","author":"Beyne-Rauzy","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2007.01.013_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1468-3083.2004.00869.x","article-title":"Scleromyositis (scleroderma\/polimyositis overlap) is an entity","volume":"18","author":"Jablonska","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2007.01.013_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","article-title":"The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl","volume":"71","author":"Marguerie","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2007.01.013_bib28","first-page":"1393","article-title":"Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients","volume":"29","author":"Franceschini","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.013_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.013_bib30","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.013_bib31","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar1862","article-title":"In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype","volume":"8","author":"Chinoy","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2007.01.013_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies","volume":"85","author":"O'Hanlon","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2007.01.013_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s001090050381","article-title":"Identification of an alpha-helical epitope region on the PM\/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides","volume":"78","author":"Bl\u00fcthner","year":"2000","journal-title":"J Mol Med"},{"key":"10.1016\/j.autrev.2007.01.013_bib34","first-page":"124","article-title":"Sero-clinical aspects of autoantibodies to a PM\/Scl peptide with special emphasis on a cohort of 495 systemic sclerosis patients","author":"Mahler","year":"2006"},{"key":"10.1016\/j.autrev.2007.01.013_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-2249.2002.01991.x","article-title":"Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations","volume":"130","author":"Van Eenennaam","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2007.01.013_bib36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.1780330508","article-title":"Immunogenetic associations of scleroderma-related antinuclear antibodies","volume":"33","author":"Genth","year":"1990","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T19:02:39Z","timestamp":1683745359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997207000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1568997207000249"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2007.01.013","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}